We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Fujifilm Cellular Dynamics

News List

Fujifilm Cellular Dynamics and PhenoVista Biosciences Enter Drug Discovery Partnership contractpharma
January 07, 2022
Enables access to services for phenotypic and high content screening imaging using iPSC-derived differentiated cells.
R&D Alliance for Eye Disease Cell Therapies contractpharma
May 18, 2021
BlueRock Therapeutics, Fujifilm Cellular Dynamics, and Opsis Therapeutics enter R&D pact to discover and develop cell therapies for eye diseases.
Fujifilm Cellular Dynamics and Lonza Enter Cell Therapy Partnership contractpharma
November 17, 2020
Fujifilm Cellular Dynamics, a global developer and manufacturer of human induced pluripotent stem cells (iPSC) technologies, and Lonza Walkersville, Inc., a leading global GMP iPSC manufacturer, have entered into a partnership.
Axxam and Fujifilm Cellular Dynamics Enter Alliance contractpharma
October 10, 2020
Axxam S.p.A. and Fujifilm Cellular Dynamics Inc. announced a strategic alliance to improve the drug discovery process.